Cancer Research Cancer Research Funding Available  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 50, 4946-4950, August 15, 1990]
© 1990 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sherwood, S. W.
Right arrow Articles by Schimke, R. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sherwood, S. W.
Right arrow Articles by Schimke, R. T.

Flow Cytometric Characterization of Antifolate Resistance in Cultured Mammalian Cells Using Fluoresceinated Methotrexate and Daunorubicin1

Steven W. Sherwood, Yehuda G. Assaraf, Arturo Molina and Robert T. Schimke2

Departments of Biological Sciences [S. W. S., Y. G. A., R. T. S.] and Medicine (Oncology) [A. M.], Stanford University, Stanford, California 94305

We have studied antifolate-resistant rodent cell lines with respect to dihydrofolate reductase gene expression and expression of the "classic" multidrug resistance phenotype by flow cytometry. Using a series of antifolate-resistant and colchicine-resistant Chinese hamster ovary cell lines obtained by single-step and stepwise selection protocols, we show that viable cell staining with fluoresceinated methotrexate and daunorubicin correlates well with drug resistance and expression of dihydrofolate reductase protein and the "classic" MDR phenotype in these cell lines. We show that flow cytometric analysis makes it possible to rapidly assess the potentially complex drug resistance phenotype(s) of cells selected with hydrophilic and lipophilic antifolates.

1 Y. G. A. is supported by a fellowship from the John D. and Catherine T. MacArthur Foundation. A. M. is supported by Robert Wood Johnson Foundation (grant 14546) and funds donated in the memory of Frances Eiger. This work was supported by grant NIH CA16318 to R. T. S.

2 To whom requests for reprints should be addressed, at Department of Biological Sciences, Stanford University, Stanford, CA 94305.

Received 10/ 5/89. Revised 5/10/90.


This article has been cited by other articles:


Home page
JCBHome page
Y. G. Strukov, Y. Wang, and A. S. Belmont
Engineered chromosome regions with altered sequence composition demonstrate hierarchical large-scale folding within metaphase chromosomes
J. Cell Biol., July 7, 2003; 162(1): 23 - 35.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1990 by the American Association for Cancer Research.